WG
AVEO

Winton Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Winton Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-19,235
Closed -$111K – 1491
2020
Q4 		$111K Sell
19,235
-25,973
-57% -$149K 0.01% 1252
2020
Q3 		$269K Sell
45,208
-2,223
-5% -$11K 0.01% 1278
2020
Q2 		$244K Sell
47,431
-10,284
-18% -$64.9K 0.01% 1324
2020
Q1 		$209K Sell
57,715
-6,855
-11% -$34K 0.01% 1245
2019
Q4 		$403K Buy
64,570
+4,176
+7% +$30.7K 0.01% 1297
2019
Q3 		$510K Buy
60,394
+57,583
+2,048% +$428K 0.01% 1083
2019
Q2 		$19K Buy
+2,811
New +$24.1K ﹤0.01% 1111

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Winton Group's AVEO Position: Q1 2021 in Review

Winton Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2021, closing a stake of 19,235 shares — an estimated $111K sold.

Winton Group first reported a position in AVEO in Q2 2019 and held it in 7 quarters. The position peaked at $510K in Q3 2019. 76 funds tracked by Wall St. Rank hold AVEO as of Q1 2021.

  • Winton Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Winton Group sold 19,235 AVEO Pharmaceuticals, Inc. shares in Q1 2021, an estimated $111K.
  • Winton Group first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2019 and held it in 7 quarters.
  • Winton Group's AVEO Pharmaceuticals, Inc. position peaked at $510K in Q3 2019.
  • 76 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2021.

Based on Winton Group's 13F filing for Q1 2021, filed 21 Jul 2021.